Hi, I'm new to next-gen sequencing and we have a nice, new MiSeq. Although, I've seen the post about not using adapter trimming on the MiSeq I think our customers might want to. We're mostly just doing PCR amplicons (not human) and bacterial resequencing and assembly. How do I know if adapter trimming needs to be done? Any information about adapter trimming would be great! I'm pretty good with the basics of how to run the MiSeq but hazy on the software/bioinformatics ends of things!
-
-
Search and read some more. Assuming you're using "standard" adapters and library prep, you should trim adapters if a significant portion of your inserts are shorter than your read lengths (thus reading into the distal adapter).
Also, if you're sequencing amplicons, you should certainly trim out (or at least be aware of), the primer sequences as they are entirely sequence of synthetic DNA. -
Thanks ECO! This whole first run has been a learning experience/problem. When the MiSeq was installed and I was trained we only had the v1 chemistry. Now that we have the v2 chemistry (but not the hardware update), my inserts are too small. So I had only ~200-300 bp inserts but did 2x250 reads. I think this probably led to me reading into my adapter in some cases. I also had a huge hangup with the Velvet assembler because of the massive overlap in reads!Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment